February 12, 2013 / 12:10 PM / 5 years ago

Reckitt Benckiser strikes deal for BMS drugs in Latam

LONDON, Feb 12 (Reuters) - Reckitt Benckiser said on Tuesday it had struck a three-year collaboration deal with Bristol-Myers Squibb for a number of over-the-counter remedies in Brazil, Mexico and other parts of Latin America.

The British consumer goods group, which will pay Bristol an initial $482 million, has an option to purchase the brands from the U.S. drugmaker at the end of the three-year period.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below